Immunotherapy has revolutionized cancer treatment by harnessing the body’s immune system to target and destroy cancer cells. Unlike traditional treatments, immunotherapy aims to enhance the body’s natural defenses. One of the most notable advancements is the development of immune checkpoint inhibitors, such as pembrolizumab (Keytruda) and nivolumab (Opdivo). These drugs block proteins that prevent immune cells from attacking cancer, allowing the immune system to recognize and kill cancer cells more effectively. CAR-T cell therapy, another breakthrough, involves modifying a patient’s T cells to better target cancer. As research progresses, immunotherapy continues to show promise for treating a variety of cancers, including melanoma, lung cancer, and lymphoma.
